1. Home
  2. ESQ vs TBPH Comparison

ESQ vs TBPH Comparison

Compare ESQ & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esquire Financial Holdings Inc.

ESQ

Esquire Financial Holdings Inc.

HOLD

Current Price

$100.73

Market Cap

944.4M

Sector

Finance

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$13.94

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESQ
TBPH
Founded
2006
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
944.4M
1.0B
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
ESQ
TBPH
Price
$100.73
$13.94
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$118.00
$29.20
AVG Volume (30 Days)
60.3K
423.6K
Earning Date
04-23-2026
06-01-2026
Dividend Yield
0.78%
N/A
EPS Growth
4.68
N/A
EPS
4.32
0.88
Revenue
N/A
$15,386,000.00
Revenue This Year
$22.47
$70.90
Revenue Next Year
$10.25
N/A
P/E Ratio
$23.88
$21.42
Revenue Growth
N/A
N/A
52 Week Low
$69.14
$7.90
52 Week High
$119.86
$21.03

Technical Indicators

Market Signals
Indicator
ESQ
TBPH
Relative Strength Index (RSI) 41.64 23.39
Support Level $99.97 $13.58
Resistance Level $106.32 $14.76
Average True Range (ATR) 3.98 0.97
MACD -0.90 -0.41
Stochastic Oscillator 17.43 12.30

Price Performance

Historical Comparison
ESQ
TBPH

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: